NCT06477211View on ClinicalTrials.gov

DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

292

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

January 20, 2025

Conditions
Lung AdenocarcinomaSurgeryPrognostic Cancer Model
Trial Locations (1)

210008

Nanjing Drum Tower hospital, Nanjing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Nanjing University

OTHER

NCT06477211 - DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma | Biotech Hunter | Biotech Hunter